Work

Correction: CPX-351 vs. conventional chemotherapy cardiotoxicity in high-risk AML: a post hoc phase III trial analysis

Year: 2026

Type: erratum

Source: Cardio-Oncology

DOI: 10.1186/s40959-026-00502-1

Authors: Joshua D. Mitchell, Michael Pfeiffer, John Boehmer, John Gorcsan, Shunsuke Eguchi, Yoshiyuki Orihara, Nalina Dronamraju, Sonja Dhani, Stefan Faderl, Tara L. Lin, Geoffrey L. Uy, Jeffrey E. Lancet, Jorge E. Cortes

Institutions: Washington University in St. Louis, Pennsylvania State University, Penn State Milton S. Hershey Medical Center, Jazz Pharmaceuticals (Ireland), University of Kansas, Moffitt Cancer Center, Augusta University

Language: English

Topic: Chemotherapy-induced cardiotoxicity and mitigation

Subfield: Cardiology and Cardiovascular Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $2,790

OpenAlex ID: W7162145000

Cites: 1

Cited by:

Related to: